Effects of BSO and DEM on thiol-level and radiosensitivity in HeLa cells. 1984

O Vos, and G P van der Schans, and W S Roos-Verhey

Reduction of the intracellular GSH and NPSH levels in HeLa cells by BSO and DEM treatments was determined. The effect of a 16 to 22 hr incubation with BSO at 37 degrees C, resulting in a depletion of GSH and NPSH to about 10 and 50%, respectively, and the effect of a 50 min incubation with DEM resulting in a reduction of GSH and NPSH to about 30 and 60%, respectively, on radiation sensitivity were studied. As parameters for radiation damage, single and double strand DNA breaks (ssb and dsb) and cell killing were used. Furthermore, repair of ssb and dsb were followed in the first 30 to 120 min after radiation, respectively. BSO and DEM treatment gave a small sensitization for the 3 types of radiation damage (ssb, dsb and cell killing) in aerobic condition. In hypoxic condition the sensitizing effect of both compounds on dsb was larger than the effect on ssb. Pretreatment with BSO and DEM had no influence on repair of ssb and dsb when cells were irradiated in air, but when cells were irradiated in hypoxia, repair was somewhat inhibited after pretreatment with DEM. It can be postulated that a reduction of the intracellular GSH level by BSO and DEM treatment affects cellular radiosensitivity both by a competitive mechanism between GSH and O2 and by inhibition of enzymatic repair of DNA breaks, the latter only in the case of DEM treatment.

UI MeSH Term Description Entries
D008298 Maleates Derivatives of maleic acid (the structural formula (COO-)-C
D008717 Methionine Sulfoximine Sulfoximine, Methionine
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013438 Sulfhydryl Compounds Compounds containing the -SH radical. Mercaptan,Mercapto Compounds,Sulfhydryl Compound,Thiol,Thiols,Mercaptans,Compound, Sulfhydryl,Compounds, Mercapto,Compounds, Sulfhydryl

Related Publications

O Vos, and G P van der Schans, and W S Roos-Verhey
May 1994, International journal of radiation oncology, biology, physics,
O Vos, and G P van der Schans, and W S Roos-Verhey
April 1992, The Journal of veterinary medical science,
O Vos, and G P van der Schans, and W S Roos-Verhey
January 1972, Radiobiologiia,
O Vos, and G P van der Schans, and W S Roos-Verhey
September 1974, Radiation research,
O Vos, and G P van der Schans, and W S Roos-Verhey
January 1972, Radiobiologiia,
O Vos, and G P van der Schans, and W S Roos-Verhey
April 1987, Biochemical and biophysical research communications,
O Vos, and G P van der Schans, and W S Roos-Verhey
January 1984, Cancer research,
O Vos, and G P van der Schans, and W S Roos-Verhey
January 1972, Radiobiologiia,
O Vos, and G P van der Schans, and W S Roos-Verhey
May 1989, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!